BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goyal N, Jain N, Rachapalli V, Cochlin DL, Robinson M. Non-invasive evaluation of liver cirrhosis using ultrasound. Clin Radiol. 2009;64:1056-1066. [PMID: 19822238 DOI: 10.1016/j.crad.2009.05.010] [Cited by in Crossref: 75] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Domenicali M, Tufoni M, Bevilacqua V, Benazzi B, Ricci CS, Tovoli A, Napoli L, Caraceni P, Bernardi M. Dorsal acoustic windows may ameliorate liver ultrasound in patients with chronic liver disease and meteorism/obesity/ascites. J Med Ultrasonics 2013;40:399-408. [DOI: 10.1007/s10396-013-0445-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Kang J, Kwon H, Cho J, Oh J, Nam K, Yoon S, Kang M, Lee S, Han S. Comparative study of shear wave velocities using acoustic radiation force impulse technology in hepatocellular carcinoma: the extent of radiofrequency ablation. Gut Liver 2012;6:362-7. [PMID: 22844566 DOI: 10.5009/gnl.2012.6.3.362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
3 Bazan I, Ramos A, Calas H, Ramirez A, Pintle R, Gomez TE, Negreira C, Gallegos FJ, Rosales AJ. Possible patient early diagnosis by ultrasonic noninvasive estimation of thermal gradients into tissues based on spectral changes modeling. Comput Math Methods Med 2012;2012:275405. [PMID: 22654958 DOI: 10.1155/2012/275405] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Ying M, Leung G, Lau TY, Tipoe GL, Lee ES, Yuen QW, Huang YP, Zheng YP. Evaluation of liver fibrosis by investigation of hepatic parenchymal perfusion using contrast-enhanced ultrasound: an animal study. J Clin Ultrasound. 2012;40:462-470. [PMID: 22847895 DOI: 10.1002/jcu.21969] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
5 Nasr P, Hilliges A, Thorelius L, Kechagias S, Ekstedt M. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 2016;51:1126-32. [DOI: 10.3109/00365521.2016.1172336] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
6 Buell JF, Tranchart H, Cannon R, Dagher I. Management of Benign Hepatic Tumors. Surgical Clinics of North America 2010;90:719-35. [DOI: 10.1016/j.suc.2010.04.006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
7 Shin NY, Kim MJ, Lee MJ, Han SJ, Koh H, Namgung R, Park YN. Transient elastography and sonography for prediction of liver fibrosis in infants with biliary atresia. J Ultrasound Med. 2014;33:853-864. [PMID: 24764341 DOI: 10.7863/ultra.33.5.853] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
8 Zhang EL, Zhang ZY, Wang SP, Xiao ZY, Gu J, Xiong M, Chen XP, Huang ZY. Predicting the severity of liver cirrhosis through clinical parameters. J Surg Res 2016;204:274-81. [PMID: 27565061 DOI: 10.1016/j.jss.2016.04.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
9 Ran H, Ye X, Zheng Y, Zhang D, Wang Z, Chen J, Madoff D, Gao J. Spleen Stiffness and Splenoportal Venous Flow: Assessment Before and After Transjugular Intrahepatic Portosystemic Shunt Placement. Journal of Ultrasound in Medicine 2013;32:221-8. [DOI: 10.7863/jum.2013.32.2.221] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
10 Göbel T, Schadewaldt-Tümmers J, Greiner L, Poremba C, Häussinger D, Erhardt A. Transient elastography improves detection of liver cirrhosis compared to routine screening tests. World J Gastroenterol 2015; 21(3): 953-960 [PMID: 25624730 DOI: 10.3748/wjg.v21.i3.953] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
11 Cobbold JFL, Patel D, Taylor-robinson SD. Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques: Imaging in non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2012;27:1281-92. [DOI: 10.1111/j.1440-1746.2012.07127.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
12 Goldberg DJ, Dodds K, Rychik J. Rare problems associated with the Fontan circulation. Cardiol Young 2010;20:113-9. [DOI: 10.1017/s1047951110001162] [Cited by in Crossref: 41] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
13 Liu GJ, Ji Q, Moriyasu F, Xie XY, Wang W, Wong LH, Lin MX, Lu MD. Value of contrast-enhanced ultrasound using perflubutane microbubbles for diagnosing liver fibrosis and cirrhosis in rats. Ultrasound Med Biol. 2013;39:2158-2165. [PMID: 23969165 DOI: 10.1016/j.ultrasmedbio.2013.05.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
14 Sartoris R, Calandra A, Lee KJ, Gauss T, Vilgrain V, Ronot M. Quantification of Pancreas Surface Lobularity on CT: A Feasibility Study in the Normal Pancreas. Korean J Radiol 2021;22:1300-9. [PMID: 33938646 DOI: 10.3348/kjr.2020.1049] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yen YH, Kuo FY, Chen CH, Hu TH, Lu SN, Wang JH, Hung CH. Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practice. Medicine (Baltimore) 2019;98:e16270. [PMID: 31277150 DOI: 10.1097/MD.0000000000016270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 Baratta F, Pastori D, Bartimoccia S, Cammisotto V, Cocomello N, Colantoni A, Nocella C, Carnevale R, Ferro D, Angelico F, Violi F, Del Ben M. Poor Adherence to Mediterranean Diet and Serum Lipopolysaccharide are Associated with Oxidative Stress in Patients with Non-Alcoholic Fatty Liver Disease. Nutrients 2020;12:E1732. [PMID: 32531941 DOI: 10.3390/nu12061732] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
17 Amarneh M, Akhter A, Rajput MZ, Labrecque DR, Abu-yousef M. Gallbladder Scalloping, Mammillated Caudate Lobe, and Inferior Vena Cava Scalloping. Academic Radiology 2018;25:1374-80. [DOI: 10.1016/j.acra.2018.02.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Bane O, Peti S, Wagner M, Hectors S, Dyvorne H, Markl M, Taouli B. Hemodynamic measurements with an abdominal 4D flow MRI sequence with spiral sampling and compressed sensing in patients with chronic liver disease. J Magn Reson Imaging 2019;49:994-1005. [PMID: 30318674 DOI: 10.1002/jmri.26305] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
19 Putz FJ, Verloh N, Erlmeier A, Schelker RC, Schreyer AG, Hautmann MG, Stroszczynski C, Banas B, Jung EM, Jung F, Fornal M. Influence of limited examination conditions on contrast-enhanced sonography for characterising liver lesions. CH 2019;71:267-76. [DOI: 10.3233/ch-189417] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 5.7] [Reference Citation Analysis]
20 Björklund J, Laursen TL, Sandahl TD, Møller HJ, Vilstrup H, Ott P, Grønbæk H. High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study. Orphanet J Rare Dis 2018;13:169. [PMID: 30241550 DOI: 10.1186/s13023-018-0910-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Kiessling I, Bzyl J, Kiessling F. Molecular ultrasound imaging and its potential for paediatric radiology. Pediatr Radiol 2011;41:176-84. [PMID: 20680621 DOI: 10.1007/s00247-010-1779-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
22 Wang L. Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine. Hepat Med 2010;2:111-24. [PMID: 24367211 DOI: 10.2147/HMER.S9052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Li N, Ding H, Fan P, Lin X, Xu C, Wang W, Xu Z, Wang J. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography. Ultrasound Med Biol. 2010;36:1066-1075. [PMID: 20620694 DOI: 10.1016/j.ultrasmedbio.2010.04.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
24 Han JY, Cho JH, Kwon HJ, Nam KJ. Predicting portal hypertension as assessed by acoustic radiation force impulse: correlations with the Doppler ultrasound. Br J Radiol. 2012;85:e404-e409. [PMID: 22815421 DOI: 10.1259/bjr/74648924] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
25 Baratta F, Pastori D, Tozzi G, D'Erasmo L, Di Costanzo A, Arca M, Ettorre E, Ginanni Corradini S, Violi F, Angelico F, Del Ben M. Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease. Liver Int. 2019;39:2301-2308. [PMID: 31392821 DOI: 10.1111/liv.14206] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
26 Alfaleh FZ, Alswat K, Helmy A, Al-hamoudi W, El-sharkawy M, Omar M, Shalaby A, Bedewi MA, Hadad Q, Ali SM, Alfaleh A, Abdo AA. The natural history and long-term outcomes in patients with chronic hepatitis C genotype 4 after interferon-based therapy. Liver Int 2013;33:871-83. [PMID: 23490034 DOI: 10.1111/liv.12127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
27 Patel KD, Abeysekera KW, Marlais M, Mcphail MJ, Thomas HC, Fitzpatrick JA, Lim AK, Taylor-robinson SD, Thomas EL. Recent advances in imaging hepatic fibrosis and steatosis. Expert Review of Gastroenterology & Hepatology 2014;5:91-104. [DOI: 10.1586/egh.10.85] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
28 Schaffner D, von Elverfeldt D, Deibert P, Lazaro A, Merfort I, Lutz L, Neubauer J, Baumstark MW, Kreisel W, Reichardt W. Phase-contrast MR flow imaging: A tool to determine hepatic hemodynamics in rats with a healthy, fibrotic, or cirrhotic liver. J Magn Reson Imaging 2017;46:1526-34. [PMID: 28240794 DOI: 10.1002/jmri.25677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
29 Kim KH, Jang BK, Chung WJ, Hwang JS, Kweon YO, Tak WY, Lee HJ, Lee CH, Suh JI. Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis. Korean J Hepatol. 2011;17:220-225. [PMID: 22102389 DOI: 10.3350/kjhep.2011.17.3.220] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
30 Cheung AC, Lapointe-Shaw L, Kowgier M, Meza-Cardona J, Hirschfield GM, Janssen HL, Feld JJ. Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes. Aliment Pharmacol Ther. 2016;43:283-293. [PMID: 26559762 DOI: 10.1111/apt.13465] [Cited by in Crossref: 67] [Cited by in F6Publishing: 52] [Article Influence: 9.6] [Reference Citation Analysis]
31 Liu J, Cheng X, Guo Z, Wang Z, Li D, Kang F, Li H, Li B, Cao Z, Nassal M. Truncated active human matrix metalloproteinase-8 delivered by a chimeric adenovirus-hepatitis B virus vector ameliorates rat liver cirrhosis. PLoS One. 2013;8:e53392. [PMID: 23301066 DOI: 10.1371/journal.pone.0053392] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
32 Baik SK. Haemodynamic evaluation by Doppler ultrasonography in patients with portal hypertension: a review: Haemodynamic evaluation by Doppler ultrasonography. Liver International 2010;30:1403-13. [DOI: 10.1111/j.1478-3231.2010.02326.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
33 Basavarajappa L, Baek J, Reddy S, Song J, Tai H, Rijal G, Parker KJ, Hoyt K. Multiparametric ultrasound imaging for the assessment of normal versus steatotic livers. Sci Rep 2021;11:2655. [PMID: 33514796 DOI: 10.1038/s41598-021-82153-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Saxena AK, Gupta P, Sodhi KS. Ultrasonography: Applications in Pediatric Abdomen. Indian J Pediatr 2016;83:553-64. [PMID: 26973334 DOI: 10.1007/s12098-015-1968-z] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
35 Liu X, Song JL, Wang SH, Zhao JW, Chen YQ. Learning to Diagnose Cirrhosis with Liver Capsule Guided Ultrasound Image Classification. Sensors (Basel) 2017;17:E149. [PMID: 28098774 DOI: 10.3390/s17010149] [Cited by in Crossref: 45] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
36 Soker G, Bahadir Ozturk A, Gulek B, Kuscu F, Bilge Doğan U, Yilmaz C. Doppler ultrasonography helps discriminate between cirrhotic and non-cirrhotic patients with viral B and C hepatitis. Diagn Interv Imaging. 2015; Nov 30. [Epub ahead of print]. [PMID: 26652726 DOI: 10.1016/j.diii.2015.05.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
37 Yin M, Glaser KJ, Talwalkar JA, Chen J, Manduca A, Ehman RL. Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations. Radiology. 2016;278:114-124. [PMID: 26162026 DOI: 10.1148/radiol.2015142141] [Cited by in Crossref: 156] [Cited by in F6Publishing: 136] [Article Influence: 22.3] [Reference Citation Analysis]
38 Maruyama H, Shiha G, Yokosuka O, Kumar A, Sharma BC, Ibrahim A, Saraswat V, Lesmana CR, Omata M. Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonography. Hepatol Int. 2016;10:267-276. [PMID: 26696585 DOI: 10.1007/s12072-015-9670-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
39 Leão J, Brock M, Castilho M, Scariot A, Scariot A, Braga W. Non-invasive assessment of fibrosis using color Doppler ultrasound in patients with hepatitis C virus in the Amazon rainforest, Brazil. Am J Trop Med Hyg 2012;86:273-9. [PMID: 22302863 DOI: 10.4269/ajtmh.2012.11-0561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
40 Nandivada P, Chang MI, Potemkin AK, Carlson SJ, Cowan E, Oʼloughlin AA, Mitchell PD, Gura KM, Puder M. The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy. Ann Surg 2015;261:172-9. [PMID: 24374535 DOI: 10.1097/SLA.0000000000000445] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 4.6] [Reference Citation Analysis]
41 Khairy P, Veldtman GR. Late Complications Following the Fontan Operation. Diagnosis and Management of Adult Congenital Heart Disease. Elsevier; 2018. pp. 183-92. [DOI: 10.1016/b978-0-7020-6929-1.00013-7] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Sharma S, Khalili K, Nguyen GC. Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J Gastroenterol 2014; 20(45): 16820-16830 [PMID: 25492996 DOI: 10.3748/wjg.v20.i45.16820] [Cited by in CrossRef: 93] [Cited by in F6Publishing: 67] [Article Influence: 11.6] [Reference Citation Analysis]
43 Parsikia A, Campos S, Khanmoradi K, Pang J, Balasubramanian M, Zaki R, Ortiz J. Equal 3-Year Outcomes for Kidney Transplantation Alone in HCV-Positive Patients With Cirrhosis. Int Surg 2015;100:142-54. [PMID: 25594655 DOI: 10.9738/INTSURG-D-13-00231.1] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
44 Gaia S, Campion D, Evangelista A, Spandre M, Cosso L, Brunello F, Ciccone G, Bugianesi E, Rizzetto M. Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data. Liver Int 2015;35:2027-35. [PMID: 25495478 DOI: 10.1111/liv.12761] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
45 Ballestri S, Romagnoli D, Nascimbeni F, Francica G, Lonardo A. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications. Expert Review of Gastroenterology & Hepatology 2015;9:603-27. [DOI: 10.1586/17474124.2015.1007955] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 10.0] [Reference Citation Analysis]
46 Potthoff A, Gebel M, Rifai K. Diagnostische und interventionelle Abdomensonographie. Internist 2012;53:261-70. [DOI: 10.1007/s00108-011-2957-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
47 Berzigotti A, Zoli M, Bru Saumell C, Gilabert Sole R. Ultrasound in the Non-Invasive Evaluation of Fibrosis and Portal Hypertension. In: de Franchis R, editor. Portal Hypertension V. Oxford: Wiley-Blackwell; 2011. pp. 28-36. [DOI: 10.1002/9781444393989.ch3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
48 Balabaud C, Bioulac-Sage P. Cirrhosis: what else? Gastroenterol Clin Biol. 2010;34:252-254. [PMID: 20537484 DOI: 10.1016/j.gcb.2010.03.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
49 Polimeni L, Pastori D, Baratta F, Tozzi G, Novo M, Vicinanza R, Troisi G, Pannitteri G, Ceci F, Scardella L, Violi F, Angelico F, Del Ben M. Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease. Intern Emerg Med. 2017;12:1159-1165. [PMID: 28900817 DOI: 10.1007/s11739-017-1746-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
50 Ramos A, Bazán I, Negreira C, Brum J, Gómez T, Calás H, Ruiz A, de la Rosa JM. Estimation of PSD shifts for high-resolution metrology of thickness micro-changes with possible applications in vessel walls and biological membrane characterization. Sensors (Basel) 2012;12:15394-423. [PMID: 23202216 DOI: 10.3390/s121115394] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
51 Loloi J, Patel A, McDevitt P, Bruno MA, Riley T. How Strongly Do Physical Examination Estimates and Ultrasonographic Measurements of Liver Size Correlate? A Prospective Study. Am J Med 2019;132:103-8. [PMID: 30243506 DOI: 10.1016/j.amjmed.2018.09.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Nievelstein RA, Robben SG, Blickman JG. Hepatobiliary and pancreatic imaging in children-techniques and an overview of non-neoplastic disease entities. Pediatr Radiol 2011;41:55-75. [PMID: 20967540 DOI: 10.1007/s00247-010-1858-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
53 Bird JR, Brahm GL, Fung C, Sebastian S, Kirkpatrick IDC. Recommendations for the Management of Incidental Hepatobiliary Findings in Adults: Endorsement and Adaptation of the 2017 and 2013 ACR Incidental Findings Committee White Papers by the Canadian Association of Radiologists Incidental Findings Working Group. Can Assoc Radiol J 2020;71:437-47. [DOI: 10.1177/0846537120928349] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
54 Mondésert B, Marcotte F, Mongeon F, Dore A, Mercier L, Ibrahim R, Asgar A, Miro J, Poirier N, Khairy P. Fontan Circulation: Success or Failure? Canadian Journal of Cardiology 2013;29:811-20. [DOI: 10.1016/j.cjca.2012.12.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
55 Stamm ER, Meier JM, Pokharel SS, Clark T, Glueck DH, Lind KE, Roberts KM. Normal main portal vein diameter measured on CT is larger than the widely referenced upper limit of 13 mm. Abdom Radiol (NY). 2016;41:1931-1936. [PMID: 27251734 DOI: 10.1007/s00261-016-0785-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
56 Lurie Y, Webb M, Cytter-Kuint R, Shteingart S, Lederkremer GZ. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol 2015; 21(41): 11567-11583 [PMID: 26556987 DOI: 10.3748/wjg.v21.i41.11567] [Cited by in CrossRef: 120] [Cited by in F6Publishing: 105] [Article Influence: 17.1] [Reference Citation Analysis]